1. ALLA AKTIER
  2. NYHETER
  3. NEWBURY PHARMACEUTICALS

Newbury Pharmaceuticals

Nyheter Newbury Pharmaceuticals Nyheter alla bolag

Newbury Pharmaceuticals receives international sales order valued at 8.8 million SEK

Newbury Pharmaceuticals is delighted to announce the receipt of a sales order, scheduled for delivery in May 2024, from an customer located in a key international growth market. The value of this order is approximately 8.8 million SEK.

Mr. Lars Minor, CEO of Newbury, expressed his enthusiasm: "This order underscores the strength of our international sales efforts and contributes to our sales growth. It arrives at an opportune time, aligning with the introduction of our new products in Scandinavia. We are committed to leveraging such opportunities to enhance our presence both in our core markets and internationally." 


The international sales activities are managed by Newbury's dedicated subsidiary in Switzerland. While Newbury maintains a strong focus on the Scandinavian market, it is actively exploring and capitalizing on international sales opportunities to bolster its overall sales and profitability. 

For more information, contact:

Lars Minor, CEO
lars.minor@newburypharma.com
Mobile: +46 72-377 3005

www.newburypharma.com

About Newbury Pharmaceuticals

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products with focus on specialty and branded products in the Nordics. Newbury aims to make a difference by offering treatment solutions within areas like oncology, rare diseases and neurology. The portfolio is built by leveraging experience and extensive international network. Newbury offers strategic partnerships of innovation for the benefit of the Nordic healthcare market.

Västra Hamnen Corporate Finance is the Company's Certified Adviser on Nasdaq First North and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Attachments

Newbury Pharmaceuticals receives international sales order valued at 8.8 million SEK

Datum 2024-02-22, kl 08:30
Källa MFN
Bifogade filer
Newbury Pharmaceuticals receives international sales order valued at 8.8 million SEK
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!